﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/biocon-biologics-receives-mhra-uk-approval-for-biosimilar-yesintek-17201</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/kilitch-drugs-posts-consolidated-q4-fy25-pat-at-rs-1021-cr-17202</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/torrent-pharma-reports-q4-fy25-pat-at-rs-498-cr-17203</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/gland-pharma-q4-fy25-pat-falls-to-rs-1865-cr-17204</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/divis-laboratories-inks-manufacturing-and-supply-agreement-with-global-pharma-company-17205</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/lupin-and-steincares-ink-agreement-for-ranibizumab-in-latin-america-17206</loc><lastmod>2025-05-26T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>